Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pamicogrel (KBT3022) is an inhibitor of COX.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 89.00 | |
25 mg | In stock | $ 165.00 | |
50 mg | In stock | $ 287.00 | |
100 mg | In stock | $ 463.00 | |
200 mg | In stock | $ 668.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Pamicogrel (KBT3022) is an inhibitor of COX. |
In vitro | Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury[1]. |
Synonyms | KBT3022 |
Molecular Weight | 448.53 |
Formula | C25H24N2O4S |
CAS No. | 101001-34-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 82 mg/mL (182.82 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pamicogrel 101001-34-7 Immunology/Inflammation Neuroscience COX Cyclooxygenase Inhibitor inhibit KBT 3022 KBT3022 KBT-3022 inhibitor